VS-214

N/A

Report date: 2025/12/16 10:23:14
NME

Base Information

Drug NameVS-214
Drug Alias NameUltra long-acting apelin analogs(Vasa Therapeutics Inc)VS-214VS214
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionApelin receptor agonists
TargetsApelin receptor
Therapy Area/IndicationsSarcopeniaSpinal Cord InjuriesMuscular Atrophy, Spinal +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVasa Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVasa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSarcopeniaSpinal Cord InjuriesMuscular Atrophy, Spinal +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A